Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 92.72%88.15K | 5.88%90.3K | -30.10%61.73K | -28.60%301.6K | -30.75%82.25K | -57.12%45.74K | 11.40%85.29K | -26.65%88.31K | -24.58%422.42K | -31.89%118.79K |
| Selling and administrative expenses | 94.84%84.08K | 13.22%84.45K | -33.75%50.21K | -23.61%273.78K | -29.83%80.25K | -57.92%43.15K | 9.71%74.59K | 3.11%75.79K | -17.01%358.41K | -2.99%114.37K |
| -General and administrative expense | 94.84%84.08K | 13.22%84.45K | -33.75%50.21K | -23.61%273.78K | -29.83%80.25K | -57.92%43.15K | 9.71%74.59K | 3.11%75.79K | -17.01%358.41K | -2.99%114.37K |
| Other operating expenses | 57.32%4.07K | -45.34%5.85K | -8.05%11.52K | -56.55%27.82K | -54.64%2K | -37.18%2.59K | 24.75%10.7K | -73.30%12.53K | -50.10%64.02K | -92.19%4.42K |
| Operating profit | -92.72%-88.15K | -5.88%-90.3K | 30.10%-61.73K | 28.60%-301.6K | 30.75%-82.25K | 57.12%-45.74K | -11.40%-85.29K | 26.65%-88.31K | 24.87%-422.42K | 31.89%-118.79K |
| Net non-operating interest income (expenses) | -62.92%432 | -52.35%699 | -78.33%677 | -44.74%6.78K | -73.70%1.02K | -36.20%1.17K | -35.15%1.47K | -27.15%3.12K | 8.31%12.27K | -39.11%3.89K |
| Non-operating interest income | -62.92%432 | -52.35%699 | -78.33%677 | -44.74%6.78K | -73.70%1.02K | -36.20%1.17K | -35.15%1.47K | -27.15%3.12K | 8.31%12.27K | -39.11%3.89K |
| Other net income (expenses) | 106.39%23 | 6.35%-693 | -275.98%-35.87K | 168.36%18.87K | 94.52%-416 | 79.33%-360 | -226.06%-740 | 208.11%20.38K | 98.04%-27.6K | 99.46%-7.59K |
| Gain on sale of security | 106.39%23 | 6.35%-693 | 403.39%1.93K | 76.27%-1.13K | 72.60%-416 | -11,900.00%-360 | -1,004.48%-740 | 112.02%383 | -116.46%-4.77K | -108.59%-1.52K |
| Special income (charges) | --0 | --0 | ---37.8K | --0 | --0 | --0 | --0 | --0 | 97.55%-36.12K | 98.99%-14.74K |
| -Less:Impairment of capital assets | --0 | --0 | --37.8K | --0 | --0 | --0 | --0 | --0 | -97.55%36.12K | -98.99%14.74K |
| Other non-operating income (expenses) | ---- | ---- | ---- | 50.42%20K | --0 | ---- | ---- | 866.18%20K | -64.21%13.3K | -75.30%8.67K |
| Income before tax | -95.16%-87.69K | -6.78%-90.3K | -49.56%-96.92K | 36.96%-275.95K | 33.34%-81.65K | 57.84%-44.93K | -14.72%-84.56K | 51.98%-64.81K | 77.62%-437.76K | 92.19%-122.48K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -95.16%-87.69K | -6.78%-90.3K | -49.56%-96.92K | 36.96%-275.95K | 33.34%-81.65K | 57.84%-44.93K | -14.72%-84.56K | 51.98%-64.81K | 77.62%-437.76K | 92.19%-122.48K |
| Net income continuous operations | -95.16%-87.69K | -6.78%-90.3K | -49.56%-96.92K | 36.96%-275.95K | 33.34%-81.65K | 57.84%-44.93K | -14.72%-84.56K | 51.98%-64.81K | 77.62%-437.76K | 92.19%-122.48K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -95.16%-87.69K | -6.78%-90.3K | -49.56%-96.92K | 36.96%-275.95K | 33.34%-81.65K | 57.84%-44.93K | -14.72%-84.56K | 51.98%-64.81K | 77.62%-437.76K | 92.19%-122.48K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -95.16%-87.69K | -6.78%-90.3K | -49.56%-96.92K | 36.96%-275.95K | 33.34%-81.65K | 57.84%-44.93K | -14.72%-84.56K | 51.98%-64.81K | 77.62%-437.76K | 92.19%-122.48K |
| Diluted earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75.00%-0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75.00%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.